Shenzhen Hepalink Pharmaceutical Group Co.,Ltd.’s Net Profit Dropped 76% in First Half of 2023

Shenzhen Hepalink Pharmaceutical Group Co.,Ltd. (深圳市海普瑞药业集团股份有限公司) (002399.SZ) reported a net profit of 122.4 million yuan in the first half of 2023, down 76% year-on-year.

Meanwhile, the company posted 2.7 billion yuan in revenue, down 27.8% year-on-year.

At the end of the reporting period, it had 20.8 billion yuan in total assets and 8.3 billion yuan in total liabilities, with a liability-to-asset ratio of 39.9%.